Back to search
FDAFDA · Food and drugs·Recall number D-0128-2018

Maximum Strength Zephrex-D, Pseudoephedrine HCl, 30 mg, Nasal Decongestant. 24 softgel tablets per paper carton, Distributed by Perrigo, Allegan, MI 49010, NDC 70085-151-01

Published December 27, 2017 · Recall initiated: November 8, 2017

Summary

FDA records drug Class II recall D-0128-2018, published December 27, 2017 and initiated November 8, 2017. Recalling firm: L. Perrigo Company; Status: Terminated; Reported quantity: 19,944 Cartons (24 tablets each); Lot: Lot # AF4273A; Exp. 02/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
L. Perrigo Company
Distributor
Nationwide
Lot
Lot # AF4273A; Exp. 02/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Maximum Strength Zephrex-D, Pseudoephedrine HCl, 30 mg, Nasal Decongestant. 24 softgel tablets per paper carton, Distributed by Perrigo, Allegan, MI 49010, NDC 70085-151-01 recalled?

Yes. FDA published recall D-0128-2018 on December 27, 2017. Reported hazard: Microbial Contamination of Non-Sterile Products

What should I do if I have this product?

Voluntary: Firm initiated · Letter